Co-Licensing refers to the practice of two or more companies or individuals sharing the rights to use a patented technology or other intellectual property. This can involve sharing the financial risks and rewards of the license.
How Co-Licensing Works
A co-licensing arrangement gives two or more licensees rights to the same intellectual property. The licensor grants parallel rights, either in one agreement or in matching agreements, so the same licensing asset is used by more than one party.
A real, public example makes it concrete. In a co-exclusive license agreement filed with the SEC in 2005, Stanford University licensed one invention, the use of mir-122 against the hepatitis C virus, to two companies at the same time. Each is a "Licensee," together "the Licensees," and the exclusivity is shared between the two named parties. That shared exclusivity is what "co-exclusive" means in practice. US pharmaceutical law recognizes the role too: a Kansas statute defines a co-licensee as a manufacturer that has entered an agreement with another manufacturer to make or distribute a prescription drug.
What the parties actually negotiate is field of use, territory, whether exclusivity is shared or split, and how costs and royalties divide. The contrast with co-development is clean: co-development creates new IP together, while co-licensing shares rights to IP that already exists. Licensing is the classic middle path in the build, buy, or partner decision.
Co-Licensing vs Co-Termination vs Cross-Licensing
Three similar-sounding terms that mean very different things. Google keeps testing this page on all three.
| Term | What it covers | Where you meet it |
|---|---|---|
| Co-licensing | Two or more parties share rights to the same IP | Pharma, technology, and content licensing deals |
| Co-termination | A billing mechanic that aligns all licenses to one renewal date | Software and hardware subscriptions |
| Cross-licensing | Two parties grant each other licenses to their own IP | Patent settlements and corporate separations |
The one that causes the most confusion is co-termination, because it is not an IP-rights structure at all. It is a renewal mechanic. As Cisco Meraki's documentation describes it, the co-term date is a weighted average of all active licenses against the licensed device count, so everything in an account expires on one shared date. Cross-licensing, by contrast, is a genuine exchange of rights, where each side licenses its own intellectual property to the other.
Frequently Asked Questions
What does it mean when a license is co-termed?
Co-termed means the end dates of multiple licenses are aligned to one shared expiration date, so they all renew together. It is a renewal and billing mechanic, not shared rights to the same IP. In Cisco Meraki's model, the co-term date is a weighted average of the active licenses.
What is the main benefit of co-term licensing?
One renewal date instead of many. For an account with lots of licenses added at different times, co-terming makes budgeting and renewal management far simpler, since everything comes up for renewal on the same day rather than scattered across the year.